Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2009 1
2015 4
2016 7
2018 6
2019 4
2021 5
2022 9
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Dried Blood Spot Sampling to Assess Rifampicin Exposure and Treatment Outcomes among Native and Non-Native Tuberculosis Patients in Paraguay: An Exploratory Study.
Ghimire S, Molinas G, Battaglia A, Martinez N, Gómez Paciello L, Aguirre S, Alffenaar JC, Sturkenboom MGG, Magis-Escurra C. Ghimire S, et al. Among authors: sturkenboom mgg. Pharmaceutics. 2023 Mar 29;15(4):1089. doi: 10.3390/pharmaceutics15041089. Pharmaceutics. 2023. PMID: 37111575 Free PMC article.
Voriconazole exposure is influenced by inflammation: A population pharmacokinetic model.
van den Born DA, Märtson AG, Veringa A, Punt NC, van der Werf TS, Alffenaar JC, Sturkenboom MGG, Touw DJ. van den Born DA, et al. Among authors: sturkenboom mgg. Int J Antimicrob Agents. 2023 Apr;61(4):106750. doi: 10.1016/j.ijantimicag.2023.106750. Epub 2023 Feb 8. Int J Antimicrob Agents. 2023. PMID: 36758777 Free article.
Safety of Rifampicin at High Dose for Difficult-to-Treat Tuberculosis: Protocol for RIAlta Phase 2b/c Trial.
Espinosa-Pereiro J, Ghimire S, Sturkenboom MGG, Alffenaar JC, Tavares M, Aguirre S, Battaglia A, Molinas G, Tórtola T, Akkerman OW, Sanchez-Montalva A, Magis-Escurra C. Espinosa-Pereiro J, et al. Among authors: sturkenboom mgg. Pharmaceutics. 2022 Dec 20;15(1):9. doi: 10.3390/pharmaceutics15010009. Pharmaceutics. 2022. PMID: 36678638 Free PMC article.
Exposure of anti-infective drugs and the dynamic changes of the gut microbiota during gastrointestinal mucositis in autologous stem cell transplant patients: a pilot study.
Märtson AG, da Silva Ferreira AR, Veringa A, Liu L, Wardill HR, Junier LAT, van der Werf TS, Harmsen HJM, Sturkenboom MGG, Span LF, Tissing WJE, Alffenaar JC. Märtson AG, et al. Among authors: sturkenboom mgg. Ann Hematol. 2023 Feb;102(2):421-427. doi: 10.1007/s00277-023-05091-y. Epub 2023 Jan 17. Ann Hematol. 2023. PMID: 36648505 Free PMC article.
Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis.
Gafar F, Wasmann RE, McIlleron HM, Aarnoutse RE, Schaaf HS, Marais BJ, Agarwal D, Antwi S, Bang ND, Bekker A, Bell DJ, Chabala C, Choo L, Davies GR, Day JN, Dayal R, Denti P, Donald PR, Engidawork E, Garcia-Prats AJ, Gibb D, Graham SM, Hesseling AC, Heysell SK, Idris MI, Kabra SK, Kinikar A, Kumar AKH, Kwara A, Lodha R, Magis-Escurra C, Martinez N, Mathew BS, Mave V, Mduma E, Mlotha-Mitole R, Mpagama SG, Mukherjee A, Nataprawira HM, Peloquin CA, Pouplin T, Ramachandran G, Ranjalkar J, Roy V, Ruslami R, Shah I, Singh Y, Sturkenboom MGG, Svensson EM, Swaminathan S, Thatte U, Thee S, Thomas TA, Tikiso T, Touw DJ, Turkova A, Velpandian T, Verhagen LM, Winckler JL, Yang H, Yunivita V, Taxis K, Stevens J, Alffenaar JC; Global Collaborative Group for Meta-Analysis of Paediatric Individual Patient Data in Pharmacokinetics of Anti-TB Drugs. Gafar F, et al. Among authors: sturkenboom mgg. Eur Respir J. 2023 Mar 9;61(3):2201596. doi: 10.1183/13993003.01596-2022. Print 2023 Mar. Eur Respir J. 2023. PMID: 36328357 Free PMC article. Review.
Corrigendum to "Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs" [Clin. Mass Spectrom. 14(Part A) (2019) 34-45].
Kuhlin J, Sturkenboom MGG, Ghimire S, Margineanu I, van den Elsen SHJ, Simbar N, Akkerman OW, Jongedijk EM, Koster RA, Bruchfeld J, Touw DJ, Alffenaar JC. Kuhlin J, et al. Among authors: sturkenboom mgg. J Mass Spectrom Adv Clin Lab. 2022 Aug 13;25:72. doi: 10.1016/j.jmsacl.2022.08.001. eCollection 2022 Aug. J Mass Spectrom Adv Clin Lab. 2022. PMID: 36035622 Free PMC article.
Population Pharmacokinetic Modelling and Limited Sampling Strategies for Therapeutic Drug Monitoring of Pyrazinamide in Patients with Tuberculosis.
Abolhassani-Chimeh R, Akkerman OW, Saktiawati AMI, Punt NC, Bolhuis MS, Subronto YW, Sumardi, van der Werf TS, Kosterink JGW, Alffenaar JC, Sturkenboom MGG. Abolhassani-Chimeh R, et al. Among authors: sturkenboom mgg. Antimicrob Agents Chemother. 2022 Jul 19;66(7):e0000322. doi: 10.1128/aac.00003-22. Epub 2022 Jun 21. Antimicrob Agents Chemother. 2022. PMID: 35727060 Free PMC article.
41 results